Physician profile
Barry Leber
NPI 1386757110
$1,936.59
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $815 · 2021: $115.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $468.96 | 2019-2021 | |
| Ucb, INC. | $238.96 | 2019-2020 | |
| Genzyme Corporation | $217.63 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $193.04 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $156.19 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $103.26 | 2019-2020 | |
| Allergan, INC. | $78.98 | 2020 | |
| Janssen Pharmaceuticals, INC | $52.88 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $50.16 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $49.10 | 2019-2020 | |
| Acorda Therapeutics, INC | $47.95 | 2020 | |
| Abbvie INC. | $41.84 | 2019 | |
| Mdd US Operations, LLC | $35.64 | 2019 | |
| Avanir Pharmaceuticals, INC. | $34.55 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $30.24 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $26.74 | 2019-2020 | |
| Kyowa Kirin, INC. | $24.94 | 2020 | |
| Amneal Pharmaceuticals LLC | $19.23 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.93 | 2020 | |
| Biogen, INC. | $16.68 | 2020 | |
| Amgen INC. | $16.44 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Leber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.